Clinical assessment of ramosetron HCl oral preparation in the treatment of nausea and vomiting induced by cisplatin: A multicenter, randomized, parallel-design, double-blind comparative study with ondansetron HCl

[1]  You-jian He,et al.  Comparison of the selective serotonin3 antagonists ramosetron and granisetron in treating acute chemotherapy-induced emesis, nausea, and anorexia: a single-blind, randomized, crossover study , 2000 .

[2]  U. Tirelli,et al.  Ondansetron versus granisetron in the prevention of chemotherapy‐induced nausea and vomiting , 1995 .

[3]  V. Gebbia,et al.  Ondasetron versus granisetron in the prevention of chemotherapy‐induced nausea and vomiting. Results of a prospective randomized trial , 1994, Cancer.

[4]  T. Taguchi,et al.  [Anti-emetic effect and safety of ondansetron tablet in double-blind comparison with placebo]. , 1992, Gan to kagaku ryoho. Cancer & chemotherapy.

[5]  A. Nishida,et al.  Serotonin (5-HT)3 receptor blocking activities of YM060, a novel 4,5,6,7-tetrahydrobenzimidazole derivative, and its enantiomer in anesthetized rats. , 1991, The Journal of pharmacology and experimental therapeutics.

[6]  J. Bonneterre,et al.  A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  J. Droz,et al.  Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesis. , 1990, The New England journal of medicine.

[8]  D. Gandara,et al.  GR 38032F (GR-C507/75): a novel compound effective in the prevention of acute cisplatin-induced emesis. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  G. Sanger,et al.  Neuropharmacology of emesis induced by anti-cancer therapy. , 1988, Trends in pharmacological sciences.

[10]  S B Kaye,et al.  On the receiving end--patient perception of the side-effects of cancer chemotherapy. , 1983, European journal of cancer & clinical oncology.